These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 35647861)

  • 1. SARS-CoV-2 Igg seroprevalence in IBD patients treated with biologics: first vs. second pandemic wave in a prospective study.
    Mossa M; Neri B; Montesano L; Salvatori S; Marafini I; Scucchi L; Lolli E; Massoud R; Petruzziello C; Bernardini S; Calabrese E; Monteleone G; Biancone L
    Eur Rev Med Pharmacol Sci; 2022 May; 26(10):3787-3796. PubMed ID: 35647861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low prevalence of SARS-CoV-2 infection in inflammatory bowel disease.
    Scucchi L; Neri B; Sarmati L; Mossa M; Sena G; Massoud R; Petruzziello C; Musumeci M; Marafini I; Calabrese E; Lolli E; Bernardini S; Andreoni M; Monteleone G; Biancone L
    Eur Rev Med Pharmacol Sci; 2021 Mar; 25(5):2418-2424. PubMed ID: 33755981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Seroprevalence Study of Anti-SARS-CoV-2 Antibodies in Patients with Inflammatory Bowel Disease during the Second Wave of the COVID-19 Pandemic in Italy.
    Di Ruscio M; Lunardi G; Buonfrate D; Gobbi F; Bertoli G; Piccoli D; Conti A; Geccherle A; Variola A
    Medicina (Kaunas); 2021 Oct; 57(10):. PubMed ID: 34684085
    [No Abstract]   [Full Text] [Related]  

  • 4. Seroprevalence of SARS-CoV2 in IBD Patients Treated with Biologic Therapy.
    Berte' R; Mazza S; Stefanucci MR; Noviello D; Costa S; Ciafardini C; Mileti E; Mapelli M; Pasqualato S; Pinto S; Favale A; Vecchi M; Neurath MF; Atreya R; Fantini MC; Facciotti F; Caprioli F
    J Crohns Colitis; 2021 May; 15(5):864-868. PubMed ID: 33211810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Seroprevalence of ANTI-SARS-CoV-2 antibodies in patients with inflammatory bowel disease.
    Martin-Arranz MD; García-Ramírez L; Hernandez-Perez M; Montero Vega D; Martín-Arranz E; Sánchez-Azofra M; Poza Cordon J; Rueda Garcia JL; Noci Belda J; Verges Martínez-Meco T; Blanco San Miguel P; Suarez Ferrer C
    Sci Rep; 2023 Apr; 13(1):7044. PubMed ID: 37120662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High seroprevalence against SARS-CoV-2 in non-vaccinated patients with inflammatory bowel disease from Northern India.
    Kante B; Vuyyuru SK; Gupta R; Dwivedi T; Kumar P; Mundhra S; Golla R; Virmani S; Verma M; Makharia G; Ahuja V; Kedia S
    Indian J Gastroenterol; 2023 Feb; 42(1):70-78. PubMed ID: 36738383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparing India's Second COVID Wave with the First Wave-A Single-Center Experience.
    Kapoor M; Singh BO; Panda PK; Dhanger P; Kataria A
    Recent Adv Antiinfect Drug Discov; 2022; 17(3):178-186. PubMed ID: 35770393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Severe acute respiratory syndrome coronavirus 2 infection does not worsen the course of inflammatory bowel disease in the long term.
    Neri B; D'Agostini G; Salvatori S; Mossa M; Bettin F; Mancone R; Marafini I; Lolli E; Calabrese E; Monteleone G; Biancone L
    Eur J Gastroenterol Hepatol; 2023 Sep; 35(9):948-954. PubMed ID: 37505974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Geography Influences Susceptibility to SARS-CoV-2 Serological Response in Patients With Inflammatory Bowel Disease: Multinational Analysis From the ICARUS-IBD Consortium.
    Wong SY; Wellens J; Helmus D; Marlow L; Brann S; Martinez Pazos V; Weinberg A; Moran HR; McGregor C; Vermeire S; Watanabe K; Kamikozuru K; Ahuja V; Vermani S; Lindsay JO; Kingston A; Dutta U; Kaur H; Silverberg MS; Milgrom R; Chien Ng S; Mak JWY; Cadwell K; Thompson C; Colombel JF; Satsangi J;
    Inflamm Bowel Dis; 2023 Nov; 29(11):1693-1705. PubMed ID: 37354560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic and T cell-associated responses to SARS-CoV-2 immunisation in gut inflammation (STAR SIGN study): effects of biologics on vaccination efficacy of the third dose of mRNA vaccines against SARS-CoV-2.
    Woelfel S; Dütschler J; König M; Graf N; Oikonomou V; Krieger C; Truniger S; Franke A; Eckhold A; Forsch K; Wyss J; Krupka N; Albrich W; Frei N; Geissler N; Schaub P; ; Friedrich M; Misselwitz B; Korte W; Bürgi JJ; Brand S
    Aliment Pharmacol Ther; 2023 Jan; 57(1):103-116. PubMed ID: 36307899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of Tumor Necrosis Factor-α Antagonists Is Associated With Attenuated IgG Antibody Response Against SARS-CoV-2 in Vaccinated Patients With Inflammatory Bowel Disease.
    Otten AT; Bourgonje AR; Horinga PP; van der Meulen HH; Festen EAM; van Dullemen HM; Weersma RK; van Leer-Buter CC; Dijkstra G; Visschedijk MC
    Front Immunol; 2022; 13():920333. PubMed ID: 35865529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Seroprevalence and longevity of SARS-CoV-2 nucleocapsid antigen-IgG among health care workers in a large COVID-19 public hospital in Saudi Arabia: A prospective cohort study.
    Alasmari F; Mukahal M; Alqurashi AA; Huq M; Alabdrabalnabi F; AlJurayyan A; Alkahtani SM; Assari FS; Bashaweeh R; Salam R; Aldera S; Alkinani OM; Almutairi T; AlEnizi K; Tleyjeh I
    PLoS One; 2022; 17(8):e0272818. PubMed ID: 35960736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Humoral Immunogenicity After Vaccination Against SARS-CoV-2 Infection in Inflammatory Bowel Disease Patients Under Immunosuppressive Therapy: Should We Prioritize an Additional Booster Injection?
    Macedo Silva V; Lima Capela T; Freitas M; Cúrdia Gonçalves T; Boal Carvalho P; Dias de Castro F; João Moreira M; Cotter J
    Inflamm Bowel Dis; 2023 Feb; 29(2):268-273. PubMed ID: 36099059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SARS-CoV-2 infection in patients with inflammatory bowel disease: comparison between the first and second pandemic waves.
    Bezzio C; Vernero M; Costa S; Armuzzi A; Fiorino G; Ardizzone S; Roselli J; Carparelli S; Orlando A; Caprioli FA; Castiglione F; Viganò C; Ribaldone DG; Zingone F; Monterubbianesi R; Imperatore N; Festa S; Daperno M; Scucchi L; Ferronato A; Pastorelli L; Alimenti E; Balestrieri P; Ricci C; Cappello M; Felice C; Coppini F; Alvisi P; Di Luna I; Gerardi V; Variola A; Mazzuoli S; Lenti MV; Saibeni S;
    BMC Gastroenterol; 2023 Jul; 23(1):230. PubMed ID: 37407913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of the COVID-19 outbreak and the serum prevalence of SARS-CoV-2 antibodies in patients with inflammatory bowel disease treated with biologic drugs.
    Bossa F; Carparelli S; Latiano A; Palmieri O; Tavano F; Panza A; Pastore M; Marseglia A; D'Altilia M; Latiano T; Corritore G; Martino G; Nardella M; Guerra M; Terracciano F; Sacco M; Perri F; Andriulli A
    Dig Liver Dis; 2021 Mar; 53(3):277-282. PubMed ID: 33423942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seroprevalence of Unidentified SARS-CoV-2 Infection in Hong Kong During 3 Pandemic Waves.
    Boon SS; Wong MCS; Ng RWY; Leung DTM; Chen Z; Lai CKC; Ho WCS; Huang J; Wong BKC; Fung KSC; Chan PKS
    JAMA Netw Open; 2021 Nov; 4(11):e2132923. PubMed ID: 34779848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SARS-CoV-2 antibody dynamics over time and risk factors associated with infection and long COVID-19 symptoms in large working environments.
    Hansen CB; Dvoncova K; Pérez-Alós L; Fogh K; Madsen JR; Garred CH; Jarlhelt I; Nielsen PB; Petersen SS; Fjordager CG; Lauritsen KT; Hilsted L; Boding L; Iversen KK; Hyveled L; Garred P
    J Intern Med; 2023 Jun; 293(6):763-781. PubMed ID: 37024264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SARS-CoV-2 Seroprevalence among Healthcare Workers after the First and Second Pandemic Waves.
    de Visscher N; Holemans X; Gillain A; Kornreich A; Lagasse R; Piette P; Ventura M; Thys F
    Viruses; 2022 Jul; 14(7):. PubMed ID: 35891515
    [No Abstract]   [Full Text] [Related]  

  • 19. Investigation of SARS-CoV-2 seroprevalence in relation to natural infection and vaccination between October 2020 and September 2021 in the Czech Republic: a prospective national cohort study.
    Thon V; Piler P; Pavlík T; Andrýsková L; Doležel K; Kostka D; Pikhart H; Bobák M; Klánová J
    BMJ Open; 2023 Mar; 13(3):e068258. PubMed ID: 36898746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of UK paediatric SARS-CoV-2 admissions across the first and second pandemic waves.
    Swann OV; Pollock L; Holden KA; Munro APS; Bennett A; Williams TC; Turtle L; Fairfield CJ; Drake TM; Faust SN; Sinha IP; Roland D; Whittaker E; Ladhani SN; Nguyen-Van-Tam JS; Girvan M; Donohue C; Donegan C; Spencer RG; Hardwick HE; Openshaw PJM; Baillie JK; Harrison EM; Docherty AB; Semple MG;
    Pediatr Res; 2023 Jan; 93(1):207-216. PubMed ID: 35449394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.